|
|
K-V Pharmaceutical Company - Comparative Business Analysis Snapshot
Business Description
K-V Pharmaceutical Company. The Group's principal activities are development, manufacture, acquisition, marketing and sale of technologically distinguished branded and generic or non-branded prescription pharmaceutical products. It operates through three segments, Branded Products Marketing, Specialty Generics Marketing and Specialty Raw Materials Marketing. It has developed and patented a wide variety of drug delivery and formulation technologies which are primarily focused in four principal areas: SITE RELEASE(R) bioadhesives; tastemasking; oral controlled release; and oral quick dissolving tablets. Currently, it owns more than 224 US and foreign trademarks.
Competitor Analysis
This analysis compares K-V Pharmaceutical Company with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
